Israel -
ebraică -
Ministry of Health
מארין קיי - גלייז לשיער
הייר פקטורי בעמ - עיצוב קל ותוספת ברק לשיער
Israel -
ebraică -
Ministry of Health
מארין קיי - טיפות סרום לשיער
הייר פקטורי בעמ - טיפוח השיער ותיקון קצוות שרופים
Israel -
ebraică -
Ministry of Health
ג'ל עיניים
לו לה מעבדות ביו קוסמטיות בעמ - צמצום קמטים וקמטוטים
Israel -
ebraică -
Ministry of Health
דספרל 0.5 גרם
novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.
Israel -
ebraică -
Ministry of Health
דספרל 0.5 גרם
novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine
Israel -
ebraică -
Ministry of Health
דספרל 0.5 גרם
novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine
Israel -
ebraică -
Ministry of Health
ספזמומן טבליות
genmedix , israel - otilonium bromide - טבליה - otilonium bromide 40 mg - otilonium bromide - otilonium bromide - treatment of irritable bowel, pain and spasm of the distal enteric tract.
Israel -
ebraică -
Ministry of Health
רקורמון iu 5000
roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 5000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative